Ventyx Biosciences logo
Ventyx Biosciences
VTYX | NASDAQ
Chart Builder DCF Calculator
$14.00
$0.00 (0.00%)
At close: Mar 3, 2026, 4:00 PM ET

Ventyx Biosciences Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
– – – – – –
– – – – – –
– – – – – –
-148.45M -207.99M -113.14M -67.15M -7.05M -4.18M
13.42M 15.07M 4.67M 78K 358 146
-135.12M -192.96M -108.43M -83.75M -28.17M -4.33M
-135.12M -192.96M -108.43M -83.75M -28.17M -4.47M
31.45M 32.23M 25.4M 8.67M 684K 628K
117M 175.77M 87.74M 58.48M 6.37M 3.55M
– – – – – –
148.45M 207.99M 113.14M 67.15M 7.05M 4.18M
– – – 99K 358K 146K
– – – – – –
148.45M 207.99M 113.14M 67.15M 7.05M 4.18M
– – – – – –
68.48M 58.54M 52.47M 50.41M 50.3M 1.96M
68.48M 58.54M 52.47M 50.41M 50.3M 1.96M
-1.97 -3.30 -2.06 -1.69 -0.56 -2.29
-1.97 -3.30 -2.06 -1.69 -0.56 -2.29
-133.77M -192.02M -107.96M -83.62M – -1K
-135.12M -192.96M -108.43M -83.65M -7.05M -4.18M
1.35M 941K 470K 30K 7.05M 4.18M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.